Sanara MedTech, Inc. is a healthcare company in the United States that specializes in developing and offering innovative technologies to enhance clinical results and lower healthcare costs in the chronic and surgical wound and skincare sectors. With an ESG score of 23.5, it is classified as a medium-risk company. Sanara MedTech's range of products, including CellerateRX Surgical Activated Collagen, HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel, provides comprehensive wound and skincare solutions for patients across different care settings.